Zaderej Karen L. 4
4 · EyePoint Pharmaceuticals, Inc. · Filed May 15, 2025
Insider Transaction Report
Form 4
Zaderej Karen L.
Director
Transactions
- Purchase
Common Stock
2025-05-14$5.42/sh+5,000$27,100→ 21,500 total - Purchase
Common Stock
2025-05-15$5.47/sh+5,000$27,350→ 26,500 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.41 to $5.42. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.45 to $5.48. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.